 |
Entrada Therapeutics
Last updated: January 16, 2024
Founder Leo Qian
Country: USA | Funding: $201.6M (+)
Website: https://www.entradatx.com/
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases such as Duchenne muscular dystrophy (DMD).
Website: https://www.entradatx.com/
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases such as Duchenne muscular dystrophy (DMD).